These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30776396)

  • 1. Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma.
    Tabatabaei SN; Derbali RM; Yang C; Superstein R; Hamel P; Chain JL; Hardy P
    J Control Release; 2019 Mar; 298():177-185. PubMed ID: 30776396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
    Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
    Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
    Wu XZ; Cui HP; Lv HJ; Feng L
    Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells.
    Passos Gibson V; Derbali RM; Phan HT; Tahiri H; Allen C; Hardy P; Chain JL
    Int J Pharm; 2020 Nov; 589():119824. PubMed ID: 32861768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma.
    Shields CL; Ramasubramanian A; Rosenwasser R; Shields JA
    Retina; 2009 Sep; 29(8):1207-9. PubMed ID: 19734768
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
    Sun Z; Zhang A; Jiang T; Du Z; Che C; Wang F
    Int J Clin Exp Pathol; 2015; 8(11):14521-7. PubMed ID: 26823772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable reduction-responsive polymeric micelles for enhanced delivery of melphalan to retinoblastoma cells.
    Li J; Wang J; Zhang X; Xia X; Zhang C
    Int J Biol Macromol; 2019 Dec; 141():997-1003. PubMed ID: 31521654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seed-targeting anti-miR-21 inhibiting malignant progression of retinoblastoma and analysis of their phosphorylation signaling pathways.
    Ding Y; Wu M; Liu J; Wu C; Huang R; Zhu R; Fei J
    Exp Eye Res; 2014 May; 122():1-8. PubMed ID: 24607444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
    Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
    Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
    Padrón-Pérez N; Català-Mora J
    J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
    [No Abstract]   [Full Text] [Related]  

  • 13. Surface-Modified Melphalan Nanoparticles for Intravitreal Chemotherapy of Retinoblastoma.
    Sims LB; Tyo KM; Stocke S; Mahmoud MY; Ramasubramanian A; Steinbach-Rankins JM
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1696-1705. PubMed ID: 31009525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR-3619-5p in Retinoblastoma.
    Yan G; Su Y; Ma Z; Yu L; Chen N
    Cell Struct Funct; 2019; 44(1):51-60. PubMed ID: 30905893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma.
    Wang Z; Yao YJ; Zheng F; Guan Z; Zhang L; Dong N; Qin WJ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5624-5629. PubMed ID: 29271995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH; Marr BP; Brodie SE; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2014 Aug; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraocular surgery with melphalan irrigation for vitreous hemorrhage in an only eye with retinoblastoma.
    Yarovoy AA; Ushakova TL; Gorshkov IM; Polyakov VG; Golubeva OV; Gorovtsova OV; Krivovyaz OS
    Eur J Ophthalmol; 2015 Dec; 26(1):e17-9. PubMed ID: 26428220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E
    Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.